GlassScriptPhysician profile
Robert B Meek
NPI 1316035447
$6,496.55
in general payments reported to CMS, 2019-2025
25 companies · $1,302 in 2025
The $1,302 reported for 2025 was more than what 84% of Otolaryngology providers received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $307 · 2020: $115 · 2021: $307 · 2022: $787 · 2023: $1,462 · 2024: $2,216 · 2025: $1,302.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,775 · Honoraria: $148 · Education: $57.82.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,774.60 |
| Honoraria | $148.02 |
| Education | $57.82 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Neurent Medical Limited | $1,379.86 | 2023-2024 | Neuromark Radiofrequency Console, Neuromark Device |
| Glaxosmithkline, LLC. | $1,123.85 | 2021-2025 | Nucala |
| Regeneron Healthcare Solutions, INC. | $1,119.49 | 2019-2025 | Dupixent |
| Genzyme Corporation | $922.89 | 2019-2025 | |
| Optinose US, INC. | $387.37 | 2021-2025 | |
| Inspire Medical Systems, INC. | $325.07 | 2023-2025 | Inspire |
| Phathom Pharmaceuticals, INC. | $222.87 | 2024-2025 | Voquezna |
| Aerin Medical INC. | $216.14 | 2022-2025 | |
| Carl Zeiss Meditec USA, INC. | $148.02 | 2023 | Kinevo 900 |
| Stryker Corporation | $110.69 | 2019-2020 | |
| Sanofi-Aventis U.S. LLC | $99.99 | 2022 | |
| Hikma Pharmaceuticals USA | $68.82 | 2023-2025 | Ryaltris |
| Pfizer INC. | $64.81 | 2022-2023 | |
| Astrazeneca Pharmaceuticals LP | $57.53 | 2020-2025 | Tezspire |
| Hologic Sales and Service, LLC | $33.20 | 2023-2024 | Coolseal Generator |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., INC. | $30.78 | 2021 | |
| Medtronic USA, INC. | $28.10 | 2019 | |
| Alk-Abello, INC | $24.40 | 2021 | |
| Phadia US INC. | $23.92 | 2022 | |
| Arbor Pharmaceuticals, INC. | $21.51 | 2019 | |
| Greer Laboratories, INC. | $18.78 | 2022 | |
| Vertex Pharmaceuticals Incorporated | $18.40 | 2025 | |
| Integra Lifesciences Corporation | $18.00 | 2025 | Inspira Air, Acclarent Aera, Relieva Spinplus Nav |
| Acclarent, INC | $17.06 | 2023 | Relieva Spinplus |
| Glenmark Therapeutics INC. | $15.00 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Meek listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.